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exposure to inflammatory mediators, DCs undergo phenotypic 
and functional maturation, a state characterized by the up- 
regulation of class II major histocompatibility complex (MHC 
II) and costimulatory molecules (CD80/CD86) and the produc-
tion of cytokines such as IL-12. Upon maturation, DCs in tissues 
migrate into afferent lymphatics and move to the T cell areas of 
lymph nodes, where they encounter naive T cells and initiate adap-
tive immune responses (Butcher and Picker, 1996). The apoptosis 
of DCs, upon completion of their task of antigen presentation, 
appears to serve as a negative immunoregulatory mechanism that 
may be crucial in controlling the magnitude of immune reactions 
against a given antigen (Hildeman et al., 2007). It has been dem-
onstrated that elimination of DCs in experimental animals leads 
to immunologic ignorance or even paralysis of antigen-specific 
T cells after antigen exposure (Jung et al., 2002). Accordingly, 
the induction of premature DC death by immunomodulatory 
drugs appears to be a major pharmacologic principle of anti- 
inflammatory treatments (Hackstein and Thomson, 2004). In 
contrast, defects in DC apoptosis lead to DC accumulation, and 
through chronic lymphocyte activation, the development of 
autoimmunity (Chen et al., 2006).
The anti-inflammation effects of BA have been well-established 
and accumulated evidence indicates that BA may have potential 
immunomodulatory properties (Kubo et al., 1984; Chung et al., 
1995; Lin and Shieh, 1996; Krakauer et al., 2001; Zhang et al., 2003; 
Zeng et al., 2007; Li et al., 2009). However, it effects on DCs have 
not been addressed. In this study, we used murine BM-derived DCs 
(BMDCs) to analyze its direct effects on DCs.
INTRODUCTION
Baicalin (BA) is a major flavonoid constituent (Figure 1) 
found in the traditional Chinese medicinal herb Baikal skull-
cap (Scutellaria baicalensis Georgi), known as “Huang qin” in 
China and “Ogon” in Japan, which has been widely used for the 
treatment of various diseases such as pneumonia, hepatitis, and 
diarrhea (Huang et al., 1986). Previous studies have demonstrated 
that BA possesses a wide range of pharmacological and biological 
activities such as anti-inflammatory, anti-allergic, antimicrobial, 
antioxidant, and anti-tumor properties (Zhang et al., 2003). Its 
anti-inflammatory activity has been estimated in various animal 
models of acute and chronic inflammation (Kubo et al., 1984; 
Lin and Shieh, 1996; Zeng et al., 2007). Evidence shows that 
its anti-inflammatory actions are associated with the suppres-
sion of functions of various inflammatory cells and inhibition 
the production of pro-inflammatory mediators such as TNF-α, 
interleukin (IL)-1, and PGE
2
 (Chung et al., 1995; Krakauer et al., 
2001). Recently, it is reported that BA can inhibit the proliferation 
of mouse T-lymphocytes stimulated with various mitogens and 




 phase (Li et al., 2009). The results 
of these studies indicate that BA may have pronounced immu-
noregulatory properties, although the underlying mechanisms 
still remain to be fully elucidated.
Dendritic cells (DCs) are potent antigen-presenting cells that 
initiate lymphocyte activation (Banchereau and Steinman, 1998; 
Banchereau et al., 2000). They develop from BM precursors and 
then migrate via the bloodstream to almost every tissue, where 
they reside as immature DCs. During pathogen invasion, or after 
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MATERIALS AND METHODS
REAGENTS
Baicalin (purity >99%) was purchased from National Institute for 
the Control of Pharmaceutical and Biological Products, China. 
Lipopolysaccharide (LPS) and RPMI-1640 were purchased from 
Sigma (St Louis, MO, USA). Fetal calf serum was purchased from 
GIBCO-BRL (Gland Island, NY, USA). Recombinant mouse 
 granulocyte–macrophage colony-stimulating factor (GM-CSF) and 
IL-4 were purchased from R&D System (Minneapolis, MN, USA). 
Fluorescein-5-isothiocyanate (FITC)-anti-mouse CD11c, PE-anti-
mouse CD80, PE-Cy5-anti-mouse CD86, and anti-murine Fc 
receptor monoclonal antibodies were purchased from PharMingen 
(San Diego, CA, USA). The J-aggregate forming lipophilic cation 
5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyan
ine iodide (JC-1) was purchased from Molecular Probes (Eugene, 
OR, USA). Annexin V-FITC Apoptosis Detection kit was purchased 
from Keygen Biotech. Co., Ltd (Nanjing, China). All other chemicals 
used were of the highest grade available commercially.
CULTURE OF BONE MARROW-DERIVED DCs
Bone marrow-derived DCs were generated according to the method 
described previously (Inaba et al., 1992) with some modification. 
In brief, BM cells were flushed from the femurs and tibiae of female 
C57BL/6 mice (purchased from Shanghai SLAC Laboratory Animal 
Co., Ltd, Shanghai, China), filtered through a Falcon 100-μm nylon 
cell strainer (BD Labware), and depleted of red blood cells by 5 min 
incubation in ACK lysis buffer (0.15 M NH
4





EDTA, pH 7.4). Whole BM cells were plated in six-well 
plates (BD Labware) in RPMI-1640 supplemented with 10% FCS, 
GM-CSF (10 ng/ml), and IL-4 (10 ng/ml), and incubated at 37°C 
and 5% CO
2
. Three days later, the floating cells (mostly granulo-
cytes) were removed, and the adherent cells were replenished with 
fresh medium containing GM-CSF and IL-4. Non-adherent and 
loosely adherent cells were harvested on day 6 as immature DC 
(typically contained >90% cells expressing CD11c and MHC II on 
the surface, as determined by flow cytometry). To stimulate DCs 
maturation, LPS (500 ng/ml) was added to the culture on day 5 
as indicated. For analysis of BA effects on DC development, BA 
(2–50 μM) was added on day 3.
PHENOTYPIC MARKER ANALYSIS
Dendritic cells harvested on day 6 were washed and suspended in 
fluorescence-activated cell-sorting analysis (FACS) Buffer (phos-
phate buffered saline containing 0.1% bovine serum albumin 
and 0.01% NaN
3
), and stained with the fluorescence-conjugated 
monoclonal antibodies recognizing CD11c, CD80, or CD86 in 
the  presence of anti-murine Fc receptor monoclonal antibody as 
described previously (Zhang et al., 2004). Samples were analyzed 
by flow cytometry on a FACSCalibur (Becton Dickinson, USA) 
with the CellQuest software package.
IL-12 ASSAY
Interleukin-12 levels in the supernatants of BMDCs were deter-
mined by ELISA kits (Bender MedSystems, Vienna, Austria), 
according to the manufacturer’s instructions.
DETECTION OF APOPTOSIS
The annexin V-FITC binding and propidium iodide (PI) stain-
ing assay were used to assess apoptosis of DCs as described pre-
viously (Koopman et al., 1994). 1 × 106 cells were stained with 
the annexin V-FITC and PI provided with the Annexin V-FITC 
Apoptosis Detection kit (purchased from Keygen Biotech. Co., Ltd, 
Nanjing, China), according to the manufacturer’s instructions. 
Stained cells were analyzed via a FACSCalibur and the CellQuest 
software (Becton Dickinson, USA). Annexin V positive cells were 
determined as apoptosis cells.
ASSAY FOR MITOCHONDRIAL MEMBRANE POTENTIAL
Mitochondrial membrane potential (∆ψ
m
) was determined by 
flow cytometry using J-aggregate forming lipophilic cationic 
probe JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimida
zolcarbocyanine iodide) following the manufacturer’s protocol 
(Molecular Probes, Eugene, OR, USA), and as described previ-
ously (Cossarizza et al., 1993). In brief, JC-1 was dissolved in 
dimethyl sulfoxide (5 mg/ml), and 50 μl were added to 10 ml 
of medium. 5 × 105 DCs were incubated with 2 ml of medium 
containing JC-1 for 15 min at 37°C and then washed twice with 
PBS. Cells were then resuspended in 0.5 ml of PBS and ana-
lyzed on a FACSCalibur (Becton Dickinson, USA) to detect green 
fluorescence at excitation/emission wavelengths of 485/530 nm 
and red fluorescence at excitation/emission wavelengths of 
550/595 nm. Since JC-1 exhibits potential-dependent accumu-
lation in mitochondria, indicated by a fluorescence emission 
shift from green (∼525 nm) to red (∼590 nm), mitochondrial 
depolarization is indicated by a decrease in the red-to-green 
fluorescence– intensity ratio.
STATISTICS
All data were expressed as the mean values ± SD. Differences 
between groups were examined for statistical significance using 
the Student’s t-test. A value of p < 0.05 was considered statistically 
significant.
RESULTS
EFFECTS OF BA ON DC MATURATION AND APOPTOSIS
The effect of BA on DCs was initially investigated in BM cell cul-
tured for 6 days with GM-CSF and IL-4, which generates mainly 
BMDCs. BA (0–50 μM) was added on day 3, and LPS (500 ng/ml) 
was added on day 5 to stimulate DC maturation. The surface expres-
sions of CD11c, CD80, and CD86 on BA-treated and -untreated 
DCs were examined by flow cytometry, and levels of IL-12 in the 
supernatants were measured by ELISA. The results demonstrated 
that more than 90% of non-adherent and loosely adherent cells 
Figure 1 | The chemical structure of BA.
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A significant degree of apoptosis was detected in the BA-treated 
DC, as shown by an increased phosphatidyl exposure using annexin 
V-FITC (Figure 2E).
COMPARISON OF BA-INDUCED APOPTOSIS IN IMMATURE  
AND MATURE DC
We further compared BA-induced apoptosis in mature DCs and 
immature DCs. In this experiment, the day-6 DCs stimulated with 
LPS were used as mature DCs, because they highly expressed CD80/
CD86 and secreted high level of IL-12. In comparison, the day-6 DCs 
without stimulation by LPS were used as immature DCs. Mature 
and immature DCs were treated with 50 μM of BA for different time 
were CD11c+ cells, and LPS stimulation markedly up-regulated 
the expression of CD80 and CD86 within the CD11c+ population 
(Figures 2A,D) and induced substantial release of IL-12 to the 
culture supernatants (Figure 2C), suggesting most cells harvested 
on day 6 were DCs. BA inclusion showed no effects on the up-
regulation of CD80/CD86 expression in response to the stimulation 
of LPS (Figures 2A,D), but resulted in a concentration-dependent 
reduction of total numbers of viable CD11c+ cells recovered on day 
6 of culture (Figure 2B), and significantly suppressed the release 
of IL-12 to culture supernatants (Figure 2C). To examine whether 
BA reduced cell recovery by inducing cell death, apoptosis in the 
day-6 DCs was further assessed by FACS after annexin V/PI staining. 
Figure 2 | effects of BA on bone marrow-derived DC (BMDC) maturation 
and apoptosis. (A) Effects of BA on the up-regulation of CD80/CD86 
expressions on day-6 BMDCs in response to LPS stimulation. (B) Effect of BA 
on numbers of viable CD11c+ cells recovered on day 6 of culture BM cells 
(expressed as percentages of total viable number of CD11c+ cells in non-
treatment control). (C) Effect of BA on the release of IL-12 into supernatants. 
(A–C) Results were obtained from three independent experiments and 
presented as mean values (±SD). *p < 0.05 vs. LPS alone control by Student’s 
t-test. (D) Representative histograms showing CD80 and CD86 expression on 
day-6 BMDCs from three independent experiments. (e) The percentage of 
apoptosis in day-6 BMDCs determined by FACS, using annexin V/PI staining. The 
results are representative of three independent experiments.
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(24–72 h) or with graded concentrations of BA (12.5–50 μM) for 
48 h, then cellular apoptosis was assessed by FACS after annexin V/PI 
staining. BA-induced apoptosis in both mature and immature DCs in 
time- and dose-dependent way and immature DCs were more sensi-
tive for BA-induced apoptosis than mature DC (Figures 3 and 4).
EFFECTS OF BA ON MITOCHONDRIAL MEMBRANE POTENTIAL IN DCs
One of the early critical events in apoptosis is the loss/disruption of 
mitochondrial membrane potential (∆ψ
m
) in the cells, which even-
tually causes the initiation and activation of apoptotic cascades. We 
sought to determine whether BA-treatment had any effect on the ∆ψ
m
 
in DCs using JC-1 staining. Figure 5 shows treatment of DCs with 
BA resulted in dose-dependent increase in the proportion of green 
fluorescence-positive cells (indicating loss of mitochondrial membrane 
potential) in both immature DCs and mature DCs, and higher propor-
tion of green fluorescence-positive cells were detected in BA-treated 
immature DCs. These results confirm that BA induced the loss of ∆ψ
m
 
in DCs, which is more profound in immature DCs than in mature DCs.
DISCUSSION
This is the first study demonstrating that BA can evoke apoptosis 
in DCs. BA addition into cytokine-driven cultures of murine BM 
cells resulted in a reduced recovery of CD11c+ cells and less produc-
tion of IL-12, but shown no effects on the up-regulation of CD80/
CD86 expression in response to the stimulation of LPS, suggest-
ing BA has no influence on DC maturation, but may induce DC 
Figure 3 | Baicalin-induced apoptosis in immature and mature DCs in a time-dependent way. Immature and mature DCs were treated with 50 μM of BA for 
different time (24–72 h), then cells were harvested and apoptosis was assayed by flow cytometry, using annexin V/PI staining. Representative results of three 
independent experiments were presented.
Figure 4 | Baicalin-induced apoptosis in immature and mature DCs in a 
dose-dependent way. Immature and mature DCs were treated with BA 
(0–50 μM) for 48 h, then cells were harvested and the percentage of 
apoptosis was determined by flow cytometry, using annexin V/PI staining. 
Results were obtained from three independent experiments and presented as 
mean values (±SD). *p < 0.05 vs. 0 control, #p < 0.05 vs. mature DC control by 
Student’s t-test.
apoptosis. The fact that BMDCs underwent strong apoptosis in 
the presence of BA in a time- and dose-dependent manner further 
confirmed its pro-apoptotic activity. Interestingly, immature DCs 
Zhang et al. Baicalin induced DC apoptosis
Frontiers in Pharmacology | Pharmacology of Natural Products  March 2011 | Volume 2 | Article 15 | 4
REFERENCES
Banchereau, J., Briere, F., Caux, C., 
Davoust, J., Lebecque, S., Liu, Y. J., 
Pulendran, B., and Palucka, K. (2000). 
Immunobiology of dendritic cells. 
Annu. Rev. Immunol. 18, 767–811.
Banchereau, J., and Steinman, R. M. 
(1998). Dendritic cells and the control 
of immunity. Nature 392, 245–252.
Butcher, E. C., and Picker, L. J. (1996). 
Lymphocyte homing and homeosta-
sis. Science 272, 60–66.
Chen, M., Wang, Y. H., Wang, Y., 
Huang, L., Sandoval, H., Liu, Y. 
J., and Wang, J. (2006). Dendritic 
cell apoptosis in the maintenance 
of immune tolerance. Science 311, 
1160–1164.
Chung, C. P., Park, J. B., and Bae, K. H. 
(1995). Pharmacological effects of 
methanolic extract from the root of 
Scutellaria baicalensis and its flavo-
noids on human gingival fibroblast. 
Planta Med. 61, 150–153.
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the clonal expansion of antigen-specific lymphocytes. Shortly after 
the peak of the response, controlled induction of apoptosis, of both 
DCs and lymphocytes, restores homeostasis. This process is critical 
to ensure protective immunity and avoid lymphoid neoplasia and 
autoimmunity (Hildeman et al., 2007). While decreased apoptosis 
can cause an overabundance of lymphocytes and possibly autoim-
mune reactions, enhanced apoptosis can result in lymphocyte deple-
tion and immunosuppression, so that the possibility to interfere with 
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et al., 2007). Previous studies have demonstrated that BA can inhibit 
the proliferation of T-lymphocytes (Li et al., 2009) and induce apop-
tosis in Jurkat T cells (Ueda et al., 2002). Here, we provide evidence 
that DCs may also primary target of BA for immunomodulation.
 Traditionally, the development of immunosuppressive drugs 
and understanding of their action has been focused on lymphocytes. 
Many classical immunosuppressive agents, such as cyclosporine 
A, rapamycin, dexamethasone, and 1,25(OH)2D3, were found 
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gesting a novel mechanism of immunomodulation by BA which 
may account, at least in part, for the immunosuppressive effects 
observed in the animal models and in clinical settings. The fact 
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were found more sensitive for BA-induced apoptosis than mature 
DC. Concordantly, BA induced more profound change of ∆ψ
m
 in 
immature DCs than in mature DCs, suggesting BA promote apop-
tosis through mitochondria-mediated pathway in DCs. A recent 
study investigated the effects of BA on apoptotic changes in multiple 
organs of severe acute pancreatitis rats. The results indicated that the 
apoptosis indexes significantly increased in lymph nodes and spleen 
in BA-treated group (Tian et al., 2009). Therefore, BA-induced DC 
apoptosis and the importance in vivo warrant further investigation.
 Apoptosis regulates many aspects of immunologic homeosta-
sis, including initiation, magnitude, and termination of immune 
responses (Giovannetti et al., 2008). During an immune response, 
Figure 5 | The impact of BA on mitochondrial transmembrane potential 
in immature and mature DC. Immature and mature DCs were treated with 
BA (0–50 μM) for 6 h, stained with JC-1 dye probe, and analyzed by flow 
cytometry. Numbers in lower right quadrant indicate the percentage of cells 
that emit only green fluorescence which is attributed to depolarized 
mitochondrial membrane. Representative of three individual experiments with 
similar results are shown.
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